SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-18-001704
Filing Date
2018-08-14
Accepted
2018-08-14 07:18:17
Documents
8
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K essa6k.htm 6-K 13432
2 Q3 2018 FINANCIAL STATEMENTS ex991.htm EX-99.1 370432
3 Q3 2018 MANAGEMENT'S DISCUSSION AND ANALYSIS ex992.htm EX-99.2 325469
4 CEO CERTIFICATION ex993.htm EX-99.3 6827
5 CFO CERTIFICATION ex994.htm EX-99.4 6815
6 NEWS RELEASE DATED AUGUST 14, 2018 ex995.htm EX-99.5 39130
7 GRAPHIC logo.jpg GRAPHIC 33711
8 GRAPHIC mda_footer.jpg GRAPHIC 1845
  Complete submission text file 0001279569-18-001704.txt   812355
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-37410 | Film No.: 181014244
SIC: 2834 Pharmaceutical Preparations